The Cyprus Stock Exchange announced the listing of a new series of Bonds of Belyrian Holdings Ltd on the Bonds Market of the CSE’s Emerging Companies Market, pursuant to Article 58(1) of the CSE Law.
Eurivex Ltd., is the Nominated Advisor of the Issuer.
Belyrian Holdings is listing a total of 700 mln bonds of USD 1 or €0.9170 nominal value. The trading of the above securities will be effected in Euro (€) and commenced on Monday, 18 July 2016. Τhe Cyprus Stock Exchange will undertake to keep the register of the above company in the CSE Central Depository/Registry.
The ISIN is CY0146550211, while the trading code is BELK.
Belyrian Holdings has previously listed $300 mln corporate bonds on the Emerging Companies Market of the CSE under the trading code BELY.
Eurivex, a licensed CSE Custodian Firm is holding both bond issues totaling USD 1 bln under its Custody.
Company
-
18 Kyriacou Matsi Ave.
-
Victory Tower, 1 st floor
-
Nicosia 1082, Cyprus
Navigate
Subscribe to our latest news
Disclaimer & Regulatory information
Eurivex Ltd is a Cyprus Investment Firm, authorized and regulated by the Cyprus Securities and Exchange Commission (CySEC), License number 114/10.
Company Reg. HE 255430. Headquartered and based in Cyprus, member of EU.
Risk warning: Investing in financial instruments and other derivatives involves a high degree of risk and may not be suitable to all investors. Trading in such financial instruments can result in both an increase and decrease in capital. If you invest through Eurivex Ltd, the value of investments may go down and your capital will be at risk. Eurivex Ltd operates a secondary market but there is no guarantee that all buy/sell orders will be completed at the desired prices and there is a risk that an order may not be completed in the Eurivex secondary market if there is no matching order. There is no guarantee that you will be able to exit early by selling your investment. Eurivex Ltd does not provide investment, tax or legal advice. If you are unsure about the suitability of an investment, you should speak to a financial adviser. Please refer to our Risk Warning available on our web site for further information.